David Nilson

David Nilson has extensive work experience in various industries. David currently holds the position of Chief Development Officer (CDO) at EVōQ nano since January 2023. Prior to this, they were the Executive Vice President at EVōQ Bio from October 2022 to February 2023. David also served as the Vice President - Biotechnology & Pharmaceuticals at EVōQ nano from August 2020 to January 2023.

Before their time at EVōQ nano, David worked at Attostat, Inc. as the Vice President of Biotechnology & Pharmaceuticals in August 2020. David held this role for a brief period.

From 2017 to 2020, David worked at MetaSource where they held the positions of Associate Vice President - Client Services from August 2018 to August 2020, and Senior Director - Client Services from January 2017 to August 2018.

Prior to MetaSource, David founded and served as the Managing Partner of Nilsson | Brown, a management, operations, and technology consulting firm. David held this role from October 2015 to August 2020.

David's earlier experiences include working as a Consultant at NBCUniversal, Inc. from February 2002 to September 2016, and as the Vice President - Strategy & Business Development at Orca Health from July 2014 to April 2015.

David also held prominent positions at Intermountain Healthcare, including General Manager - BioRepository from March 2011 to July 2014, and Manager - Oncology Clinical Trials from November 2007 to March 2011. David began their career as a Clinical Research Coordinator at the University of Utah from June 2006 to November 2007.

David Nilson completed their Bachelor of Science in Exercise Physiology at the University of Utah in 2002. Later, they pursued their Master of Business Administration (MBA) at the University of Utah - David Eccles School of Business from 2011 to 2013.